Clinical Trials Browser

Phase 2 × Metformin × Genitourinary × Clear all

NCT02365597 2026-05-08

An Efficacy and Safety Study of Erdafitinib (JNJ-42756493) in Participants With Urothelial Cancer

Phase 2 Active not recruiting

239 enrolled 32 charts 1 FDA

Urothelial Cancer

NCT02946996 2026-03-05

Study of Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients Receiving Androgen Deprivation Therapy

Phase 2 Terminated

41 enrolled 8 charts

Prostatic Neoplasms

NCT06884683 2025-03-19

NivoMet

Phase 2 Terminated

Carcinoma, Renal Cell

NCT02431676 2024-08-28

SPIRIT

Phase 2 Completed

121 enrolled 12 charts

BreastDermatologicGastrointestinalGenitourinaryGynecologicThoracic

Breast Neoplasms, Colonic Neoplasms, Kidney Neoplasms, Liver Neoplasms, Lung Neoplasms, Melanoma, Pancreatic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Endometrial Neoplasms

NCT01996696 2024-01-30

PREMIUM

Phase 2 Terminated

Prostatic Neoplasms, Weight Gain, Metabolic Syndrome

NCT03379909 2023-09-21

TROJAN

Phase 2 Recruiting

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT02640534 2023-06-27

Investigation of Metformin in Patients With Castration Resistant Prostate Cancer in Combination With Enzalutamide vs. Enzalutamide Alone

Phase 2 Terminated

Prostatic Neoplasms

NCT02420652 2023-02-08

PRIMA

Phase 2 Terminated

27 enrolled 6 charts

Prostatic Neoplasms

NCT02176161 2022-10-18

Metformin Prostate Cancer Adjuvant Trial

Phase 2 Completed

59 enrolled 8 charts

Prostatic Neoplasms

NCT02945813 2022-04-14

SAKK 08/15 - PROMET - Salvage Radiotherapy +/- Metformin for Patients With Prostate Cancer After Prostatectomy

Phase 2 Terminated

Prostatic Neoplasms

NCT02614859 2022-03-29

BIMET-1

Phase 2 Completed

29 enrolled 10 charts

Prostatic Neoplasms

NCT04925063 2021-06-14

The Effect of Metformin in Patients With Newly Diagnosed mHSPC

Phase 2 Not yet recruiting

Prostatic Neoplasms

NCT04926155 2021-06-14

The Effect of Metformin in Patients With Metastatic Castration-resistant Prostate Cancer

Phase 2 Unknown

Prostatic Neoplasms

NCT02497638 2021-04-19

LIGAND

Phase 2 Withdrawn

Prostatic Neoplasms

NCT01243385 2019-08-13

Metformin Hydrochloride as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms

NCT01677897 2019-03-05

MetAb-Pro

Phase 2 Completed

Prostatic Neoplasms

NCT01796028 2018-06-06

TAXOMET

Phase 2 Completed

Prostatic Neoplasms

NCT01620593 2018-05-23

Castration Compared to Castration Plus Metformin as First Line Treatment for Patients With Advanced Prostate Cancer

Phase 2 Completed

41 enrolled 7 charts

Prostatic Neoplasms

NCT01433913 2018-01-10

Metformin Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery

Phase 2 Completed

20 enrolled 17 charts

Prostatic Neoplasms

NCT01215032 2017-05-15

Metformin in Castration-Resistant Prostate Cancer

Phase 2 Terminated

21 enrolled 8 charts

Prostatic Neoplasms

NCT03137186 2017-05-02

Mansmed

Phase 2 Unknown

Prostatic Neoplasms

NCT02360618 2016-07-11

Metformin and Simvastatin Use in Bladder Cancer

Phase 2 Unknown

Urinary Bladder Neoplasms

NCT01561482 2015-07-22

Study of Metformin With Simvastatin for Men With Prostate Carcinoma

Phase 2 Withdrawn

Prostatic Neoplasms

NCT01733836 2013-05-24

Prostate Cancer Active Surveillance Metformin Trial

Phase 2 Withdrawn

Prostatic Neoplasms

NCT01478308 2013-03-06

Metformin With Standard Taxotere and Prednisone in the Treatment of Castration Resistant Prostate Cancer

Phase 2 Withdrawn

Prostatic Neoplasms

NCT00881725 2012-06-19

ANIMATE

Phase 2 Terminated

Prostatic Neoplasms